Q2025 : We are pleased to announce that we successfully completed the MDR (Medical Devices Regulation) and GDP (Good Distribution Practices) trainings.

This allows us to continue building the future of Medi3S, while ensuring our customers receive the highest quality, trust, and expertise.

Together, we are shaping a future on strong and compassionate medical care.

 Q2 2025 :  we are pleased to inform you that, in addition to our existing services, we now also distribute medical devices, including import services.

Q3 2025 : After months of discussions with a manufacturer, we can proudly announce that a Belgian premiere is on its way: a revolutionary wound dressing based on the latest biotechnological developments. The first clinical results from the U.S. are particularly positive with FDA approval, and CE marking is expected in Q1 2026. More to come